Wnt/β-catenin signaling pathway is essential for the protective effect of Fat soluble Vitamins (A, D, E, and K) on colorectal cancer

Authors

  • Hossna M. Ismail Professional Clinical Nutrition Master Program, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.
  • Ehab S. Shatat Medical Laboratories Department, High Institute of Applied Health Science, Badr, Egypt.
  • Abdel-Aziz S. Shatat Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

DOI:

https://doi.org/10.5530/gjpb.2025.2.5

Abstract

An essential regulatory pathway involved in many biological processes, such as embryonic development, tissue homeostasis, and cancer progression, is the Wnt/β-catenin signaling pathway. One of the main characteristics of Colorectal Cancer (CRC) is the  dysregulation of the Wnt/β-catenin signaling pathway, which plays a significant role in tumor development, invasion, and metastasis. Adenomatous polyposis coli (APC) gene mutations account for 80–90% of sporadic cases of CRC. Typically, APC mutations occur early in the development of CRC. APC normally suppresses tumors by encouraging β-catenin degradation. Fat-soluble vitamins, such as A, D, E, and K, are essential for many physiological functions. They may also interact with signaling pathways like the Wnt/β-catenin pathway. The involvement of the Wnt/β-catenin signaling pathway in the protective effect of Fatsoluble vitamins against CRC is the main topic of this review. Moreover, a comprehensive understanding of the underlying molecular mechanisms of fat-soluble vitamins-mediated Wnt/β-catenin signaling pathway regulation is required to target therapeutic targets for CRC prevention and treatment effectively.

Metrics

Metrics Loading ...
GRAPHICAL ABSTRACT
CITATION
DOI: 10.5530/gjpb.2025.2.5
Published: 2025-08-27

Downloads

Published

2025-08-27

How to Cite

Hossna M. Ismail, Ehab S. Shatat, & S. Shatat, A.-A. . (2025). Wnt/β-catenin signaling pathway is essential for the protective effect of Fat soluble Vitamins (A, D, E, and K) on colorectal cancer. German Journal of Pharmaceuticals and Biomaterials, 4(2), 1–17. https://doi.org/10.5530/gjpb.2025.2.5